A Peek Into The Market Before The Trading Starts
Pre-open movers US stock futures are slightly lower this morning, after President Barack Obama won the re-election. Futures for the Dow Jones Industrial Average dropped 13 points to 13,188.00 and S&P 500 index futures fell 0.40 points to 1,424.80. Nasdaq 100 futures declined 0.25 points to 2,675.50.
A Peek Into Global Markets European markets were higher today. The STOXX Europe 600 Index surged 0.43%, London's FTSE 100 Index rose 0.34%, French CAC 40 Index climbed 0.46% and German DAX 30 index gained 0.46%.
Asian markets ended mostly higher, with Japan's Nikkei Stock Average falling 0.03%, China's Shanghai Composite dropping 0.01% and Australia's S&P/ASX 200 rising 0.68%. Hong Kong's Hang Seng index gained 0.71% and India's Sensex gained 0.45%.
Broker Recommendation Analysts at Janney Capital upgraded LivePerson (NASDAQ: LPSN) from “neutral” to “buy.” The target price for LivePerson has been lowered from $18 to $17.
LivePerson shares dropped 3.81% to $14.12 in pre-market trading.
- WellPoint (NYSE: WLP) reported a 1.2% rise in its third-quarter earnings and cut its revenue forecast for the full year. To read the full news, click here.
- Santarus (NASDAQ: SNTS) and Pharming Group NV today announced that their pivotal Phase III clinical study to evaluate the safety and efficacy of the investigational drug RUCONEST® 50 U/kg for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema met the primary endpoint of time to beginning of symptom relief. To read the full news, click here.
- Northrop Grumman (NYSE: NOC) has been selected by prime contractor Alenia Aermacchi to provide the Attitude Heading Reference System for the Israel Ministry of Defense's M-346 advanced trainer aircraft fleet. To read the full news, click here.
- MasterCard (NYSE: MA) and ING Group today announced a joint trial underway in the Netherlands that is demonstrating a new way to pay online using mobile phones. To read the full news, click here.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.